📰 Forefront Analytics News
Page 7 - Forefront Analytics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forefront Analytics. Real-time updates on events, politics, business and more.
February 2, 2024
Forefront Analytics LLC decreased its position in shares of Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) by 20.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,649 shares of the company’s stock after selling 17,100 shares during the […]
February 2, 2024
Forefront Analytics LLC trimmed its holdings in shares of iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI – Free Report) by 52.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,831 shares of the company’s stock after selling 9,851 […]
February 2, 2024
Forefront Analytics LLC lifted its stake in shares of Vanguard Small-Cap ETF (NYSEARCA:VB – Free Report) by 12.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,768 shares of the company’s stock after acquiring an additional 1,407 shares during the quarter. Vanguard […]
February 2, 2024
Forefront Analytics LLC boosted its position in Geron Co. (NASDAQ:GERN – Free Report) by 95.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,116 shares of the biopharmaceutical company’s stock after purchasing an additional 14,225 shares during the period. […]
February 2, 2024
Forefront Analytics LLC bought a new stake in shares of Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,183 shares of the company’s stock, valued at approximately $110,000. Other hedge funds have also recently bought and […]
February 2, 2024
Forefront Analytics LLC grew its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 67.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,685 shares of the company’s stock after buying an additional 13,610 shares during the period. Forefront Analytics LLC’s holdings in […]
February 2, 2024
Forbes Financial Planning Inc. raised its position in shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 1.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,182 shares of the company’s stock after buying an additional 3,219 shares […]
February 2, 2024
Avantax Advisory Services Inc. lessened its stake in iShares MSCI USA Min Vol Factor ETF (BATS:USMV – Free Report) by 5.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 320,255 shares of the company’s stock after selling 19,594 shares during the period. […]
February 2, 2024
Forefront Analytics LLC lifted its stake in shares of Vanguard Global ex-U.S. Real Estate ETF (NASDAQ:VNQI – Free Report) by 12.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,745 shares of the company’s stock after acquiring an additional 9,938 shares […]
February 2, 2024
Forefront Analytics LLC reduced its holdings in iShares TIPS Bond ETF (NYSEARCA:TIP – Free Report) by 10.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,288 shares of the exchange traded fund’s stock after selling 2,028 shares during the quarter. iShares […]